Cargando…
The PPARα pathway in Vγ9Vδ2 T cell anergy
Phosphoantigens (PAgs) activate Vγ9Vδ2 T lymphocytes, inducing their potent and rapid response in vitro and in vivo. However, humans and nonhuman primates that receive repeated injections of PAgs progressively lose their Vγ9Vδ2 T cell response to them. To elucidate the molecular mechanisms of this i...
Autores principales: | Poupot, Mary, Boissard, Frédéric, Betous, Delphine, Bardouillet, Laure, Fruchon, Séverine, L’Faqihi-Olive, Fatima, Pont, Frédéric, Mekaouche, Mourad, Ingoure, Sophie, Sicard, Hélène, Dubreuilh, Guy, Fournié, Jean-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275808/ https://www.ncbi.nlm.nih.gov/pubmed/25424910 http://dx.doi.org/10.2478/s11658-014-0218-0 |
Ejemplares similares
-
Anti-Inflammatory Properties of Dendrimers per se
por: Hayder, Myriam, et al.
Publicado: (2011) -
Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins
por: Laplagne, Chloé, et al.
Publicado: (2021) -
The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells
por: Fruchon, Séverine, et al.
Publicado: (2018) -
Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles
por: Fruchon, Séverine, et al.
Publicado: (2017) -
Nanoparticle-Based Strategies to Treat Neuro-Inflammation
por: Poupot, Rémy, et al.
Publicado: (2018)